- NASDAQ:SNDL gained 12.77% during Tuesday’s trading session.
- Sundial’s stalking horse bid for Zenabis has investors excited.
- Some promising news as April monthly cannabis sales rise in Canada.
NASDAQ:SNDL kicked the shortened Juneteenth week off with a major bid for consolidation in the Canadian cannabis industry. On Tuesday, shares of SNDL surged by 12.77% and closed the trading day at $0.35. Tuesday was one of the strangest performances from Sundial in recent memory, a downward trend that has seen the stock fall by 43% year to date.
US stocks were flying out of the long weekend, as all three major averages rebounded from the worst trading week since 2020. The Dow Jones regained 641 basis points, the S&P 500 jumped higher by 2.45% and the NASDAQ added 2.51% during the session.
On Monday, when the US markets were closed, Sundial announced that it had placed a stalking horse bid for the assets and capital of Zenabis. The now bankrupt subsidiary of Hexo (NASDAQ:HEXO) would provide Sundial with some crucial production capital, and a facility that would provide the company with upwards of 46,000 kilograms of dried cannabis on an annual basis. Investors are excited that Sundial is making aggressive moves to consolidate the Canadian sector, and showed that enthusiasm with over 113 million shares of SNDL trading hands on Tuesday.
Sundial stock forecast
Some promising news for the beleaguered Canadian cannabis sector as Statistics Canada revealed that April cannabis sales were higher on both a year over year and sequential monthly basis. In April, the country saw a modest 3.7% sequential rise in cannabis sales, reaching a total of $372.4 million CAD. Although it is a subtle increase, it is still a good sign for an industry that has been struggling to increase sales. The May monthly figures will be released at the end of July.
Like this article? Help us with some feedback by answering this survey:
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.